Michael Olson's Stock Ratings

Piper Sandler Analyst

Michael Olson is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/04/2024

Overall Average Return

51.6%

Smart Score

Overall Average Return Percentile

94th

Number of Ratings

33

Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Cracking The Code: Understanding Analyst Reviews For Incyte

Peeling Back The Layers: Exploring Incyte Through Analyst Insights

Assessing Incyte: Insights From 11 Financial Analysts

Berkshire Board Member Expresses Confidence In Warren Buffett's Successor Greg Abel: 'He Will Run The Companies ... In The Same Way That Warren Ran Them'

Canadian businessman Greg Abel is anticipated to take over the helm of Berkshire Hathaway Inc. (NYSE: BRK-A) from Warren Buffett and appears to have the full backing of at least one board member ahead of the

Oracle To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

This Analyst With 87% Accuracy Rate Sees Over 13% Upside In Amazon.com - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts

U.S. stocks closed mixed on Friday, with the Dow Jones index falling more than 100 points during the session.

In-Depth Examination Of 18 Analyst Recommendations For Amgen

Bill Gates Hired Charlie Munger's Law Firm To Handle His $130 Billion Divorce Even Though He Was Not A Divorce Lawyer — Melinda Gates Used The Lawyer Who Represented Donald Trump's 2 Ex-Wives

These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Cannabis Movers & Shakers: Latest Appointments From Khiron, MariMed, Equilibria & More

Equilibria Strengthens Women's Wellness With New CSO Equilibria named its first chief science officer, Dr. Jacqueline Jacques, a wellness industry veteran who will help the leadership team drive product development beyond hemp and design holistic coaching protocols to amplify women's wellness outcomes.

The Best Trading Research Platform

For Retail Investors and Professional Trades Alike.

Get Started for Free

Benzinga Pro on Macbook